The CRYOcheck FVIII Inhibitor Kit is for clinical laboratory use in conjunction
The CRYOcheck FVIII Inhibitor Kit is for clinical laboratory use in conjunction with a factor VIII activity assay to enable performance of a modified Nijmegen-Bethesda assay using 3.2% citrated human plasma. It enables the determination of a functional FVIII inhibitor titer to aid in the clinical management of congenital hemophilia A in individuals aged 2 years and older.
GGN,GGP
Plasma, Coagulation Control,Test, Qualitative And Quantitative Factor Deficiency
CRYOcheck Chromogenic Factor VIII is for clinical laboratory use in the quantita
CRYOcheck Chromogenic Factor VIII is for clinical laboratory use in the quantitative determination of factor VIII activity in 3.2% citrated human plasma. It is intended to be used in identifying factor VIII deficiency and as an aid in the management of hemophilia A in individuals aged 2 years and older. For in vitro diagnostic use
GGP
Test, Qualitative And Quantitative Factor Deficiency
Prepared from human source plasma and recommended as a negative control in assay
Prepared from human source plasma and recommended as a negative control in assays for lupus anticoagulant.
Prepared from human source plasma and recommended as a negative control in assay
Prepared from human source plasma and recommended as a negative control in assays for lupus anticoagulant.
CRYOcheck Hex LA is for clinical laboratory use as a qualitative test kit intend
CRYOcheck Hex LA is for clinical laboratory use as a qualitative test kit intended to aid in the detection of lupus anticoagulants (LA) in 3.2% citrated human plasma by the application of hexagonal phase phospholipids. CRYOcheck Hex LA should be used as an integrated test for lupus anticoagulant detection. For in vitro diagnostic use. The performance of this device has not been established in neonate and pediatric patient populations.
LA Control High is a high positive control plasma for use in Lupus Anticoagulant
LA Control High is a high positive control plasma for use in Lupus Anticoagulant clotting test assays
LA Control Low is a low positive control plasma for use in Lupus Anticoagulant c
LA Control Low is a low positive control plasma for use in Lupus Anticoagulant clotting test assays
REAADS Coagulation Control 2 (CC-2) ) is an assayed control plasma in coagulatio
REAADS Coagulation Control 2 (CC-2) ) is an assayed control plasma in coagulation studies for In Vitro Diagnostic Use.PRINCIPLE OF THE PROCEDURECoagulation Control 2 is tested in the same manner as citrated patient plasma samples to assess the performance of each assay run, for the parameters. Testing variables in each laboratory, including equipment, reagents, and technique may influence control recovery. Although an expected range is provided for each parameter, laboratories should establish their own expected range for their particular instrument-reagent system. Refer to Package Insert.
Assayed control used to monitor the performance of coagulation assays in the pat
Assayed control used to monitor the performance of coagulation assays in the pathological range
LA Control Low is a low positive control plasma for use in Lupus Anticoagulant c
LA Control Low is a low positive control plasma for use in Lupus Anticoagulant clotting test assays, specifically LA 1 Screening Reagent (DRVVT) and LA 2 Confirmation Reagent (DRVVT) from Siemens Healthcare Diagnostics on automated coagulation analyzers
LA Control High is a high positive control plasma for use in Lupus Anticoagulant
LA Control High is a high positive control plasma for use in Lupus Anticoagulant clotting test assays, specifically LA 1 Screening Reagent (DRVVT) and LA 2 Confirmation Reagent (DRVVT) from Siemens Healthcare Diagnostics on automated coagulation analyzers
For use as a high level assayed control for the quantitative measurement of low
For use as a high level assayed control for the quantitative measurement of low molecular weight heparin with Berichrom Heparin
For use as a high level assayed control for the quantitative measurement of unfr
For use as a high level assayed control for the quantitative measurement of unfractionated heparin with Berichrom Heparin
For use as a consistent test sample of known concentration for monitoring assay
For use as a consistent test sample of known concentration for monitoring assay conditions for the listed constituents.
George King Factor XIII Deficient plasma is fresh frozen human plasma derived fr
George King Factor XIII Deficient plasma is fresh frozen human plasma derived from a congenital Factor XIII deficient donor.
George King Positive Lupus Anticoagulant is citrated fresh frozen human plasma d
George King Positive Lupus Anticoagulant is citrated fresh frozen human plasma derived from donors who have been diagnosed with the Anti-Phospholipid Antibody Syndrome (APS).
George King Positive Lupus Anticoagulant is citrated human fresh frozen plasma d
George King Positive Lupus Anticoagulant is citrated human fresh frozen plasma derived from donors who have been diagnosed with the Anti-Phospholipid Antibody Syndrome (APS).
George King Abnormal Correlation (AbCOR) Kit is a convenience kit containing 20
George King Abnormal Correlation (AbCOR) Kit is a convenience kit containing 20 vials of select control material that can be used to correlate reagent lot numbers and/or instrument platforms. (individual product inserts are included with each kit)
George King Abnormal Correlation (AbCOR) Kit is a convenience kit containing 10
George King Abnormal Correlation (AbCOR) Kit is a convenience kit containing 10 vials of select control material that can be used to correlate reagent lot numbers and/or instrument platforms. (individual product inserts are included with each kit)
George King Factor XIII Deficient Plasma is fresh frozen citrated human plasma d
George King Factor XIII Deficient Plasma is fresh frozen citrated human plasma derived from a congenital Factor XIII deficient donor.
George King von Willebrand, Type 2B, is citrated human fresh frozen plasma deriv
George King von Willebrand, Type 2B, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 2B. This plasma is intended for use as a control in the quantitative determination of von Willebrand aG in citrated plasma.
George King von Willebrand plasma, Type 1, is citrated human fresh frozen plasma
George King von Willebrand plasma, Type 1, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 1. This plasma is intended for use as a control in the quantitative determination of von Willebrand Ag in citrated plasma.
George King Factor XIII Deficient Plasma is fresh frozen citrated human plasma d
George King Factor XIII Deficient Plasma is fresh frozen citrated human plasma derived from a congenital Factor XIII deficient donor.
George King von Willebrand plasma, Type 2A, is citrated human fresh frozen plasm
George King von Willebrand plasma, Type 2A, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 2A. This plasma is intended for use as a control in the quantitative determination of von Willebrand Ag in citrated plasma.
George King von Willebrand plasma, Type 2A, is citrated human fresh frozen plasm
George King von Willebrand plasma, Type 2A, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 2A. This plasma is intended for use as a control in the quantitative determination of von Willebrand Ag in citrated plasma.
George King von Willebrand plasma, Type 2A, is a citrated human fresh frozen pla
George King von Willebrand plasma, Type 2A, is a citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 2A. This plasma is intended for use as a control in the quantitative determination of von Willebrand Ag in citrated plasma.
George King von Willebrand plasma, Type 3, is citrated human fresh frozen plasma
George King von Willebrand plasma, Type 3, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 3. This plasma is intended for use as a control in the quantitative determination of von Willebrand factor antigen in citrated plasma.
George King von Willebrand plasma, Type 2B, is a citrated human fresh frozen pla
George King von Willebrand plasma, Type 2B, is a citrated human fresh frozen plasma derived from a donor diagnosed with vWD type 2B. This plasma is intended for use as a control in the quantitative determination of von Willebrand factor antigen in citrated plasma